Home|Journals|Articles by Year|Audio Abstracts
 

Letter to the Editor

PBS. 2016; 6(1): 41-42


Tardive Dyskinesia Associated with Paliperidone Palmitate

Sevda Korkmaz, Burcu Gündoğan.




Abstract

-Dear Editor,
Paliperidone is an atypical antipsychotic drug formed by one of the active metabolites of risperidone, 9-hydroxirisperione.1 The drug demonstrates its effects by antagonizing central dopamine type-2 (D2) and serotonin type-2 (5HT2A) receptors. It could be used in acute stage and maintenance treatment of schizophrenia, and schizoaffective and bipolar disorders. In this letter, a case of male patient, who developed tardive dyskinesia due to paliperidone palmitate, is scrutinized. The objective of this letter is to call attention to the extrapyramidal side effects of stock paliperidone such as tardive dyskinesia, albeit rare.

Key words: -Paliperidone, tardive dyskinesia, bipolar disorder






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.